Labels

Follow us on Facebook

Tuesday, August 30, 2016

Mylan blames ‘the system’ for EpiPen price hikes…and they’re right—commentary : cnbc





As it stated in cnbc

Mylan blames 'the system' for EpiPen price hikes…and they're right—commentary

Mylan blames 'the system' for EpiPen price hikes…and they're right—commentary
Mylan blames 'the system' for EpiPen price hikes…and they're right—commentary
Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.Mylan's dramatic price hikes on EpiPen, an injection device used to quickly treat individuals facing life-threatening anaphylactic shock from food allergies or insect stings, has attracted a lot of attention during this year's pre-first-day-of-school shopping season.EpiPens expire after a year, so a lot of parents are buying new ones to throw into their kids backpacks.


in addition masslive

US Sens. Elizabeth Warren, Ed Markey press Mylan on EpiPen price increases

US Sens. Elizabeth Warren, Ed Markey press Mylan on EpiPen price increases
US Sens. Elizabeth Warren, Ed Markey press Mylan on EpiPen price increases
Following scrutiny Mylan has faced in recent weeks over the high cost of its EpiPen auto-injectors, U.S. Sens.Elizabeth Warren and Ed Markey called on the drug manufacturer Tuesday to explain the increased prices for the life-saving allergic reaction treatment.The Massachusetts Democrats, in a letter signed by several senators, contended that by raising the price of EpiPens from just over $100 for two in 2009 to more than $600 today, Mylan has made the auto-injectors "so exorbitantly expensive" that many Americans are unable to access the medication.


furthermore cnbc

Senators probing EpiPen price hike received donations from Mylan PAC

Senators probing EpiPen price hike received donations from Mylan PAC
Senators probing EpiPen price hike received donations from Mylan PAC
Sen. Charles Grassley (R-Iowa), reacts to what Mylan CEO Heather Bresch had to say about the EpiPen pricing outrage.A political committee for Mylan has donated to most of the Senate committee that has asked the drugmaker to explain price increases for allergy treatment EpiPen and could grill executives in a hearing on the matter.The Mylan Inc. PAC has given $13,500 to four current members of the Senate Judiciary Committee since 2014, including $5,000 to ranking Democrat Patrick Leahy of Vermont and $5,000 to the Senate's likely next Democratic leader Chuck Schumer of New York.


No comments:

Post a Comment